Skip Main Navigation
Page Content

Save This Event

Event Saved

BREAST CANCER: DRUGS FUNDING AND TRIALS

Pink Ribbon

Thursday, 23 March 2017 from 09:00 to 17:00 (GMT)

BREAST CANCER: DRUGS FUNDING AND TRIALS

Ticket Information

Ticket Type Remaining Sales End Price Fee VAT Quantity
Full price (£79+vat; £69 FPM) 2 Tickets 1h 14m £79.00 £0.00 £15.80

Who's Going

Loading your connections...

Share BREAST CANCER: DRUGS FUNDING AND TRIALS

Event Details

BREAST CANCER: DRUGS FUNDING & TRIALS

Achieving world-class patient outcomes                    6 CPD points

A Pink Ribbon event Thursday 23 March 2017, 9-5. Faculty of Pharmaceutical Medicine, London EC1V

Theme of the Day:

To identify issues and discuss potential solutions around achieving best care and treatment for all patients with breast cancer (primary and secondary) in UK, including enhancing options for research into curative treatments for secondary breast cancer.

Preamble:

Although within the UK, generally, treatment of Breast Cancer is good, nevertheless the best possible treatment is not available to every patient with breast cancer who would benefit, within an optimal time-frame, for various reasons which will be discussed through the day.

In addition there is the general problem that secondary breast cancer is incurable currently. The purpose of the day is to explore how current initiatives, together with new unexplored initiatives can be implemented to maximise quality of treatment and cure for breast cancer within UK (and beyond, but the purpose of the day is primarily UK).

Suitable for:

Top level movers and shakers and opinion formers in healthcare, regulation, industry, politics, academia, media, third sector

 Attendees also include doctors, senior nurses, hospital administrators, other pharma personnel, researchers, civil servants, financiers, economists, lawyers, campaigners, media

 

PROGRAMME

9 Registration & coffee + exhibition

9.30 Welcome and introduction – Gerard Dugdill, publisher/coordinator Pink Ribbon

Chair: Dr Kathleen Thompson, pharmaceutical physician, breast cancer patient & author, From Both Ends of the Stethoscope

MORNING SESSIONS

SECTION ONE – THE PROBLEMS

PATIENT PERSPECTIVES

How effective is the current breast cancer drugs regime?

9.40-10.15 Major issues: limits in availability of new effective treatments for metastatic breast cancer, poor access to clinical trials, inadequate use of data to facilitate research into cure, tissue banking.

Introductions (and introduction to white paper). Group discussion: Chair + patient advocates (Jo Taylor, MetupUK; Alison Dagul, breast and ovarian patient; Julia Bradford, Metup)

SYSTEM PERSPECTIVES

What are the key challenges in drug approval and funding?

Increasing breast cancer drug costs due to regulation, prevalence, survival rates, long drug approval time. NICE. UK lagging behind other countries. Funding restraints hindering prescription. Cancer Drugs Fund

10.15-10.30 Medical perspective: cancer funding and research needs

Dr Aleksandra Filipovic, research fellow, department of surgery and cancer, Imperial College London

10.30-10.45 Pharma perspective: regulator approval and drug funding

Dr David Montgomery, medical director, Pfizer Oncology UK

10.45-11 Buyer perspective: providing adequate cancer service and drugs

Ms Raj Nijjar, Lead Cancer Pharmacist, Barts Health NHS Trust & Specialised Cancer Commissioning Pharmacist, NHS England - London Region

11-11.15 Life science + patient perspective: accelerated access review opportunities 

Dr Stuart Dollow, Head, Global Clinical Development and Medical Affairs at UCB; Founder - Vermilion Life Sciences; also, external champion to the Accelerated Access Review 

11.15-11.30 PANEL: are we clear now on the key challenges for the industry? Problems section speakers

11.30-11.45 Refreshments break

SECTION TWO - THE SOLUTIONS

DRUG DEVELOPMENT 

New ways to make and deliver drugs quickly and effectively

11.45-12 Oncologist focus: new drug possibilities, personalized medicine, genomics

Dr  Bhawna Sirohi, Consultant Medical Oncologist, Program Training Director - Medical Oncology, Barts Cancer Institute, London

12-12.30 New ways of doing drug development

Speaker one: New ways of funding research. Lesley Turner, patient advocate, Catalyst Initiative     

Speaker two: Professor Jackie Hunter, director, Benevolent Artificial Intelligence

12.30-12.45 Cancer patient data: linking the possibilities

Dr Rachael Brock, national head of cancer registration, National Cancer Registration & Analysis Service, Public Health England (PHE)

12.45-1 Clinical trial database creation: getting it perfect
Sarah Kimber, patient information manager, Cancer Research UK

1-1.15 PANEL: what one thing can we do to enhance innovative research?

Drug development section speakers      

1.15-2.15 Lunch & exhibition

AFTERNOON SESSIONS         …SOLUTIONS CONTINUED

REGULATION

New approaches for approval, cost and reimbursement

2.15-2.35 Regulatory approval of breast cancer drugs

Dr Cecilia Chisholm, medical assessor in licensing divison, medicines and healthcare products regulatory agency (MHRA)

2.35-2.50 Regulation from an EU perspective

Dr Francesco Pignatti, head of oncology, haematology and diagnostics, European Medicines Agency (EMA)

2.50-3.05 PANEL: how can we get the best possible regulation?

Panel: regulation section speakers+ extra, NHS England, NHS

3.05-3.20 Tea break

FUNDING

Collaboration: getting new drugs to patients

KEYNOTE

3.20-3.50TOWARDS PARTNERSHIP APPROACHES IN FUNDING

Possible discussion and/or speaker

3.50-4.05 The new Cancer Drugs Fund

Linda Landells, associate director – Technology Appraisals (Cancer Drugs Fund), national institute for clinical excellence (NICE)

4.05-4.25 Making drugs available earlier: how can we achieve?

Professor Peter Clark, clinical lead, CDF, NHS England

4-25-4.45 PANEL: what must we do to fund all patient needs?

Panel: funding section speakers

4.45-5 Chair’s closing remarks + call to action via white paper

Close


A Pink Ribbon event, in aid of the national hereditary breast cancer helpline

Supported by Pfizer Limited


 


Do you have questions about BREAST CANCER: DRUGS FUNDING AND TRIALS? Contact Pink Ribbon

Save This Event

Event Saved

When & Where


Faculty of Pharmaceutical Medicine
9 Angel Gate, 326a City Road
EC1V 2PT London
United Kingdom

Thursday, 23 March 2017 from 09:00 to 17:00 (GMT)


  Add to my calendar

Organiser

Pink Ribbon

Network of professionals and public seeking to eliminate breast cancer.

Features online, events, awards, newsletter, social media

  Contact the Organiser
BREAST CANCER: DRUGS FUNDING AND TRIALS
Things to do in London Conference Health

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.